OTC Dry Eye Drops Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034

The Global OTC Dry Eye Drops Market was valued at USD 1.8 billion in 2024 and is estimated to grow at a CAGR of 5.8% to reach USD 3.1 billion by 2034, driven by increasing cases of dry eye syndrome, rising screen time, and a growing elderly population. The heightened exposure to digital devices, coupled with environmental stressors such as air conditioning and pollution, contributes significantly to the prevalence of dry eye symptoms globally. These factors, along with improved consumer awareness and a surge in self-care trends, are leading to a higher adoption of over-the-counter (OTC) eye drop solutions.

Technological advancements have made preservative-free and lipid-enhanced formulations more accessible, addressing the needs of individuals with moderate to severe symptoms. Additionally, the ease of product availability via online and retail channels has enhanced accessibility for consumers. Educational efforts by healthcare professionals and expanding e-commerce networks are further contributing to the market’s sustained growth.

The OTC dry eye drops market is primarily segmented by product type, with preservative-based drops generating the highest revenue of USD 989.3 million in 2024. These formulations are widely used due to their cost-effectiveness, multi-dose packaging, and trusted performance in maintaining sterility. Despite a growing shift toward preservative-free options, preservative-based products continue to dominate owing to established consumer trust and extensive distribution.

By type, branded OTC dry eye drops led the market in 2024, accounting for USD 1.1 billion, driven by strong brand recognition, robust marketing, and innovation in product formulations. These products are often preferred by consumers seeking reliable relief with clinically backed efficacy and endorsements from healthcare providers.

Based on viscosity, low viscosity products held the largest share, reaching USD 1.3 billion in 2024. This fast-acting, water-based formulations offer effective hydration without visual disturbance, making them a go-to option for daytime users and individuals with mild to moderate dry eye symptoms.

In terms of distribution, retail pharmacies emerged as the leading channel, with projected revenues of USD 1.7 billion by 2034. Their in-store presence, immediate availability, and pharmacist support make them a trusted choice for consumers seeking dry eye solutions.

North America led the global OTC dry eye drops market in 2024 with a market size of USD 655.4 million and is projected to reach USD 1.2 billion by 2034, growing at a CAGR of 5.9%. The region’s dominance is attributed to advanced healthcare infrastructure, higher awareness levels, and greater digital device usage contributing to increased dry eye prevalence.

Key players operating in the OTC dry eye drops market include AbbVie, Alcon, Bausch Health Companies, Rohto Pharmaceutical, Prestige Consumer Healthcare, NovaBay Pharmaceuticals, Santen Pharmaceutical, Similasan Corporation, Thea Pharmaceuticals, URSAPHARM Arzneimittel, Jadran-Galenski Laboratorij, OASIS, Medicom Healthcare, and Scope Eyecare. These companies are strengthening their market positions through innovation, expanding distribution networks, and strategic collaborations to address the growing demand for effective, accessible eye care products worldwide. Show more